Description | Mkt Cap | P/E | Current Ratio | Cash per Share | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | H-Rank | C-Rank | Stars |
OGN | 5.6 B | 4.7 | 1.6 | 2.24 | 25 | 25 | 5.5 | 13 | 21 | 1 | 1 |
BIIB | 31 B | 12 | 2.3 | 13.11 | 29 | 26 | 0.40 | -1.7 | 21 | 1 | 1 |
NVS | 227 B | 13 | 0.93 | 4.16 | 33 | 39 | 9.6 | 43 | 22 | 1 | 1 |
BMY | 98 B | 6.9 | 1.2 | 3.28 | 21 | 39 | 8.7 | -16 | 22 | 1 | 1 |
GSK | 81 B | 8.7 | 0.82 | 0.73 | 28 | 32 | 9.8 | -28 | 23 | 1 | 2 |
LLY | 750 B | 43 | 1.4 | 2.95 | 31 | 37 | 26 | 66 | 20 | 2 | 2 |
GRFS | 6.1 B | 6.8 | 1.7 | 3.33 | 16 | 16 | 9.3 | -66 | 23 | 2 | 2 |
AZN | 252 B | 17 | 0.89 | 4.57 | 22 | 34 | 13 | 6.0 | 23 | 2 | 1 |
JNJ | 387 B | 15 | 1.1 | 10.58 | 29 | 36 | 4.3 | -1.6 | 24 | 2 | 0 |
SNY | 129 B | 10.0 | 1.00 | 5.43 | 14 | 24 | 7.5 | -22 | 25 | 2 | 0 |
ABBV | 335 B | 15 | 10.23 | 35 | 47 | 4.3 | -32 | 26 | 2 | 2 | |
PFE | 174 B | 10.0 | 2.10 | 22 | 18 | 4.3 | -98 | 28 | 3 | 0 | |
GILD | 95 B | 10.0 | 1.1 | 4.43 | 34 | 46 | 5.3 | 31 | 4 | 2 | |
MRK | 288 B | 11 | 2.22 | 38 | 52 | 7.2 | 32 | 4 | 2 | ||
AMGN | 180 B | 16 | 1.4 | 18.10 | 13 | 39 | 22 | 29 | 5 | 1 | |
AMRN | 255 M | -3.5 | 3.0 | 0.75 | -0.78 | -9.0 | -15 | 45 | 19 | 1 | |
SCLX | 183 M | -3.1 | 0.15 | 0.01 | -242 | -217 | 2.9 | 58 | 29 | 0 | |
MIRA | 36 M | -6.4 | 5.7 | 0.24 | 67 | 39 | 1 |
Total Records: 18. | Quotes | Help |
© George Elgin | Questions or Comments | Data last Modified 08/02/24 |
P/E | Current Ratio | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | |
Best 10% | 6.8 | 3.0 | 35 | 47 | 22 | 66 |
Best 20% | 6.9 | 1.7 | 33 | 39 | 9.8 | 66 |
Best 30% | 10.0 | 1.6 | 31 | 39 | 9.6 | 43 |
mean | 13 | 1.6 | 26 | 34 | 8.8 | 32 |
median | 11 | 1.2 | 28 | 36 | 7.3 | 28 |
tr mean | 13 | 1.6 | 26 | 34 | 8.8 | 32 |
count | 15 | 15 | 15 | 15 | 16 | 4.0 |